BNP Paribas Exane Downgrades Organon & Co. (OGN) to Neutral Post Acquisition
Tweet
Share
E-mailGet Alerts OGN Hot Sheet
Price: $13.39 -0.3%
Rating Summary:
2 Buy, 6 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23
Rating Summary:
2 Buy, 6 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 10 | New: 23
Join SI Premium – FREE
BNP Paribas Exane analyst Navaan Ty downgraded Organon & Co. (NYSE: OGN) from Outperform to Neutral.
For an analyst ratings summary and ratings history on Organon & Co. click here. For more ratings news on Organon & Co. click here.
Shares of Organon & Co. closed at $13.16 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bending Spoons valuation up to $19 Billion in U.S. IPO - Reuters
- Unifor starts contract talks with Ford for 5,150 workers
- Definium Therapeutics Inc (DFTX) PT Raised to $60 at Oppenheimer
Create E-mail Alert Related Categories
DowngradesRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
